Acutus Medical’s Pulsed Field Ablation System To Be Featured During 27th Annual AF Symposium
13 January 2022 - 10:30PM
Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia
management company focused on improving the way cardiac arrhythmias
are diagnosed and treated, today announced the company’s attendance
at the 27th Annual AF Symposium.
Cases performed at Na Homolce Hospital in Prague, Czech
Republic, by physicians Jacob Koruth, M.D., Mount Sinai Health
System, Jan Petru, M.D., Na Homolce Hospital, and Vivek Reddy,
M.D., Director, Cardiac Arrhythmia Service, Mount Sinai Health
System, will feature the AcQMap 3D Imaging and Mapping System, the
AcQBlate Force catheter*, and Acutus’ focal force sensing Pulsed
Field Ablation (PFA) system**. Petr Neuzil, M.D., Ph.D., FESC, Na
Homolce’s Head of Cardiology and Principal Investigator for the
AcQForce PFA-CE study, will present the cases on Saturday, January
15, between 10 a.m. and 12:30 p.m. ET, highlighting the versatility
of Acutus technology to map and treat a variety of arrhythmias with
a single system.
Additionally, abstract poster presentations demonstrating the
efficiency and efficacy of the AcQMap 3D Imaging and Mapping
System, as well as the AcQCross Universal Transseptal Crossing
System, will be on display. To learn more about Acutus Medical’s
complete portfolio of access, diagnostic, mapping and therapy
products, please visit https://acutusmedical.com.
The symposium brings together hundreds of leaders in the field
of electrophysiology from across the world to educate and present
the latest clinical, technological and procedural advancements for
the management of atrial fibrillation (AF). To register for the
27th Annual International AF Symposium, an informative three-day
scientific program, and for more information on CME, visit
https://www.afsymposium.com/.
*AcQBlate Force is currently indicated for RF energy in Europe
and is investigational in the U.S. **The Acutus PFA System is under
investigation in CE Mark countries.
About Acutus MedicalAcutus Medical is an
arrhythmia management company focused on improving the way cardiac
arrhythmias are diagnosed and treated. Acutus is committed to
advancing the field of electrophysiology with a unique array of
products and technologies which will enable more physicians to
treat more patients more efficiently and effectively. Through
internal product development, acquisitions and global partnerships,
Acutus has established a global sales presence delivering a broad
portfolio of highly differentiated electrophysiology products that
provide its customers with a complete solution for catheter-based
treatment of cardiac arrhythmias. Founded in 2011, Acutus is based
in Carlsbad, California.
Follow Acutus Medical on: Twitter, LinkedIn,
YouTube and Facebook.
US Media ContactsHolly Windler(619)
929-1275holly.windler@acutus.com
Adam King(260) 408-5383 acutus@levitatenow.com
Investor ContactCaroline Corner (415)
202-5678caroline.corner@westwicke.com
Acutus Medical (NASDAQ:AFIB)
Historical Stock Chart
From Nov 2024 to Dec 2024
Acutus Medical (NASDAQ:AFIB)
Historical Stock Chart
From Dec 2023 to Dec 2024